Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3017 (LINC03017) is a long intergenic non-coding RNA (lincRNA), a subset of long non-coding RNAs that are defined by their length (>200 nucleotides) and their genetic location not overlapping with protein-coding genes. LincRNAs are known to regulate gene expression through diverse mechanisms, including chromatin remodeling, influencing genome architecture, regulating transcription, RNA stabilization, and sometimes enhancer-like functions. While the general class of lincRNAs has been implicated in the fine-tuning of gene expression with tissue specificity and roles in development and disease, there are currently no published functional studies or known disease associations specific to LINC03017. LINC03017 is cataloged in human genomics and GWAS databases, but it is not considered an established therapeutic target, receptor, enzyme, or biomarker based on current evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3017 (LINC03017).